You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • TQB3909 tablet
  • Zhengzhou, Henan, China
  • +1 more
Jul 17, 2023

Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

Active, not recruiting
  • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 20, 2023

B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

Suspended
  • B-cell Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Peking, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

Not yet recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Ibrutinib 420 mg
  • (no location specified)
Jan 12, 2023

B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

Active, not recruiting
  • Chronic Lymphocytic Leukemia
    • Manhasset, New York
      Feinstein Institute for Medical research
    Jul 6, 2022

    Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

    Recruiting
    • Hypogammaglobulinemia
    • +2 more
    • Columbus, Ohio
    • +1 more
    Jan 16, 2023

    CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    Jan 20, 2023

    B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Non-Interventional Study
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 22, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Not yet recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

    Active, not recruiting
    • Recurrent Chronic Lymphoid Leukemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
    • (no location specified)
    Dec 27, 2022

    Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Observation
    • (no location specified)
    Oct 12, 2023

    B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

    Not yet recruiting
    • B-cell Malignancy
    • +7 more
    • (no location specified)
    Oct 26, 2022

    Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Fairway, Houston (SC291)

    Recruiting
    • Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Fairway, Kansas
    • +1 more
    May 30, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Leukemia
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Dec 5, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Acalabrutinib (Arm A)
    • Acalabrutinib (Arm B)
    • Bethesda, Maryland
      Research Site
    Jan 3, 2023

    Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Salt Lake City, Utah
      Huntsman Cancer Institute at University of Utah
    Jan 17, 2023

    Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Whittier, California
      Innovative Clinical Research Institute
    Aug 8, 2022